IL1B and colitis: Another former observation obtained from the investigation of adiponectin-deficient mice administered DSS showed the exacerbation of underlying colitis with an additional release of inflammatory molecules (IL-1β, IL-4, and IL-6) associated with a more pronounced activation of B cells and enhanced STAT3 signaling within the colon.